Aurobindo Pharma Q4 PAT may dip 26.6% YoY to Rs 588.1 cr: Prabhudas Lilladher

Prabhudas Lilladher has come out with its fourth quarter (January-March’ 22) earnings estimates for the Healthcare sector. The brokerage house expects Aurobindo Pharma to report net profit at Rs 588.1 crore down 26.6% year-on-year (down 2.7% quarter-on-quarter).

Net Sales are expected to decrease by 1.1 percent Y-o-Y (down 1.2 percent Q-o-Q) to Rs 5,932.9 crore, according to Prabhudas Lilladher.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 18.9 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs 1,034.1 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.